Search Results - "Shitaka, Yoshitsugu"

Refine Results
  1. 1

    Repetitive Closed-Skull Traumatic Brain Injury in Mice Causes Persistent Multifocal Axonal Injury and Microglial Reactivity by Shitaka, Yoshitsugu, Tran, Hien T, Bennett, Rachel E, Sanchez, Laura, Levy, Marilyn A, Dikranian, Krikor, Brody, David L

    “…Repetitive mild or "concussive" traumatic brain injury (TBI) can cause substantial neurologic impairment, but the pathological features of this type of injury…”
    Get full text
    Journal Article
  2. 2

    Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine by Nagakura, Akira, Shitaka, Yoshitsugu, Yarimizu, Junko, Matsuoka, Nobuya

    Published in European journal of pharmacology (05-03-2013)
    “…Alzheimer's disease is characterized by a progressive decline in cognitive function and involves β-amyloid (Aβ) in its pathogenesis. To characterize cognitive…”
    Get full text
    Journal Article
  3. 3

    Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease by Kanamaru, Takuya, Kamimura, Naomi, Yokota, Takashi, Iuchi, Katsuya, Nishimaki, Kiyomi, Takami, Shinya, Akashiba, Hiroki, Shitaka, Yoshitsugu, Katsura, Ken-ichiro, Kimura, Kazumi, Ohta, Shigeo

    Published in Neuroscience letters (05-02-2015)
    “…•We have established a novel mouse model of Alzheimer’s disease (the APP/DAL mouse).•Pathological changes and memory impairment are accelerated in the APP/DAL…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models by Kohara, Atsuyuki, Takahashi, Masayasu, Yatsugi, Shin-ichi, Tamura, Seiji, Shitaka, Yoshitsugu, Hayashibe, Satoshi, Kawabata, Shigeki, Okada, Masamichi

    Published in Brain research (29-01-2008)
    “…Abstract We describe in vitro properties and in vivo neuroprotective effects of a newly synthesized, high-affinity, selective allosteric metabotropic glutamate…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models by Kohara, Atsuyuki, Nagakura, Yukinori, Kiso, Tetsuo, Toya, Takashi, Watabiki, Tomonari, Tamura, Seiji, Shitaka, Yoshitsugu, Itahana, Hirotsune, Okada, Masamichi

    Published in European journal of pharmacology (24-09-2007)
    “…Metabotropic glutamate receptor 1 (mGlu 1 receptor) has been suggested to play an important role in pain transmission. In this study, the effects of a…”
    Get full text
    Journal Article
  8. 8

    Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice by Mitani, Yasuyuki, Yarimizu, Junko, Saita, Kyoko, Uchino, Hiroshi, Akashiba, Hiroki, Shitaka, Yoshitsugu, Ni, Keni, Matsuoka, Nobuya

    Published in The Journal of neuroscience (08-02-2012)
    “…γ-Secretase inhibitors (GSIs) reduce amyloid-β (Aβ) peptides but inevitably increase the β-C-terminal fragment (β-CTF) of amyloid precursor protein (APP),…”
    Get full text
    Journal Article
  9. 9

    Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble A beta 42 without affecting other A beta pools by Mitani, Yasuyuki, Yarimizu, Junko, Akashiba, Hiroki, Shitaka, Yoshitsugu, Ni, Keni, Matsuoka, Nobuya

    Published in Journal of neurochemistry (01-05-2013)
    “…Given that amyloid- beta 42 (A beta 42) is believed to be a culprit in Alzheimer's disease (AD), reducing A beta 42 production should be a potential…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Amelioration of cognitive deficits in plaque‐bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools by Mitani, Yasuyuki, Yarimizu, Junko, Akashiba, Hiroki, Shitaka, Yoshitsugu, Ni, Keni, Matsuoka, Nobuya

    Published in Journal of neurochemistry (01-05-2013)
    “…Given that amyloid‐β 42 (Aβ42) is believed to be a culprit in Alzheimer's disease (AD), reducing Aβ42 production should be a potential therapeutic approach…”
    Get full text
    Journal Article
  12. 12

    Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble A[beta]42 without affecting other A[beta] pools by Mitani, Yasuyuki, Yarimizu, Junko, Akashiba, Hiroki, Shitaka, Yoshitsugu, Ni, Keni, Matsuoka, Nobuya

    Published in Journal of neurochemistry (01-05-2013)
    “…Given that amyloid-[beta] 42 (A[beta]42) is believed to be a culprit in Alzheimer's disease (AD), reducing A[beta]42 production should be a potential…”
    Get full text
    Journal Article
  13. 13

    Amelioration of cognitive deficits in plaque‐bearing A lzheimer's disease model mice through selective reduction of nascent soluble A42 without affecting other A pools by Mitani, Yasuyuki, Yarimizu, Junko, Akashiba, Hiroki, Shitaka, Yoshitsugu, Ni, Keni, Matsuoka, Nobuya

    Published in Journal of neurochemistry (01-05-2013)
    “…Abstract Given that amyloid‐β 42 (Aβ42) is believed to be a culprit in Alzheimer's disease ( AD ), reducing Aβ42 production should be a potential therapeutic…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Basic Fibroblast Growth Factor Increases Functional L-Type Ca2+ Channels in Fetal Rat Hippocampal Neurons: Implications for Neurite Morphogenesis In Vitro by Shitaka, Yoshitsugu, Matsuki, Norio, Saito, Hiroshi, Katsuki, Hiroshi

    Published in The Journal of neuroscience (15-10-1996)
    “…Basic fibroblast growth factor (bFGF) is a potent neurotrophic factor that regulates cell proliferation and differentiation during neuronal development. Here…”
    Get full text
    Journal Article
  20. 20